We started NeuroAiD on the first week of January. He started swallowing purees mid January, started eating solid food mid February, got back complete bladder control end of January, starting walking with a cane end of February, got his voice back but has been diagnosed with aphasia and all the feeling is back in his arm now although it is not strong enough to do anything with.
Nasreen Madhany (Canada)
we decided to purchase a three month supply of Neuroaid. Dad has had to learn to walk again and we are still on the journey of regaining his speech. Under instruction from this family dad is able to do most things for himself now. He has some movement in his fingers and hand and this is a work in progress.
Kathy Roff’s Father (Australia)
since he started taking the drug he has had movement in his right arm & leg... his speech has become much clearer... he has become less depressed and is eating better and has gained 3kg of weight
Malcom Wells (Australia)
I have now completed two months treatment and will soon start my third month. I have made some positive progress in terms of better control of my limbs. Shoulder in lying position is much better. Leg is also improving slowly
Anil Kumar Gupta (Bangalore, India)
During the three months following her discharge she began to weight bear again, and has now progressed to walking on a zimmer frame. The hoist is no longer used, and only one carer required. All have commented how much stronger she is now. As this improvement only happened since taking NeuroAiD™
Mark Andrews (UK)
I started a three months treatment on NeuroAiD™ a month after the stroke, and I feel I am much more alert and my memory is improving.
Carl Livermon (USA)
My motor functions have improved, I can walk unassisted when at home, I can open and close my palm although I still lack a bit of strength; Overall I am more independent in my daily activities
NeuroAiD™ is a trademark of Moleac. MLC601 (NeuroAiD™) and MLC901 (NeuroAiD™II / NurAiD™II) are 2 different proprietary formulae which have been shown to be equivalent in pharmacology and are referred as «NeuroAiD» on this page, except in case of specific mentions.